Literature DB >> 2567871

Galactose consumption and metabolism in relation to the risk of ovarian cancer.

D W Cramer1, B L Harlow, W C Willett, W R Welch, D A Bell, R E Scully, W G Ng, R C Knapp.   

Abstract

In a case-control study, consumption of dairy foods by 235 white women with epithelial ovarian cancer and by 239 control women, and activity of red blood cell galactose-1-phosphate uridyl transferase (transferase) in a subset of 145 cases and 127 controls were determined. Yogurt was consumed at least monthly by 49% of cases and 36% of controls. The mean transferase activity of cases was significantly lower than that of controls. When a ratio of lactose consumption to transferase (L/T) was calculated, cases had a mean L/T of 1.17 compared with 0.98 for controls; there was a highly significant trend for increasing ovarian cancer risk with increasing L/T ratio. Lactose consumption may be a dietary risk factor and transferase a genetic risk factor for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567871     DOI: 10.1016/s0140-6736(89)90313-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

Review 1.  Kefir: a powerful probiotics with anticancer properties.

Authors:  Mohammadreza Sharifi; Abbas Moridnia; Deniz Mortazavi; Mahsa Salehi; Marzieh Bagheri; Abdolkarim Sheikhi
Journal:  Med Oncol       Date:  2017-09-27       Impact factor: 3.064

2.  Duarte galactose-1-phosphate uridyl transferase genotypes are not associated with ovarian cancer risk.

Authors:  Melissa A Merritt; Joanne Kotsopoulos; Daniel W Cramer; Susan E Hankinson; Kathryn L Terry; Shelley S Tworoger
Journal:  Fertil Steril       Date:  2012-06-29       Impact factor: 7.329

Review 3.  Racial bias in federal nutrition policy, Part I: The public health implications of variations in lactase persistence.

Authors:  P Bertron; N D Barnard; M Mills
Journal:  J Natl Med Assoc       Date:  1999-03       Impact factor: 1.798

4.  Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89.

Authors:  F Jin; X O Shu; S S Devesa; W Zheng; W J Blot; Y T Gao
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

Review 5.  Pharmacoeconomic considerations in treating ovarian cancer.

Authors:  D Bodurka-Bevers; C C Sun; D M Gershenson
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

6.  Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes.

Authors:  Melissa A Merritt; Daniel W Cramer; Allison F Vitonis; Linda J Titus; Kathryn L Terry
Journal:  Int J Cancer       Date:  2012-07-24       Impact factor: 7.396

7.  Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer.

Authors:  Melissa A Merritt; Elizabeth M Poole; Susan E Hankinson; Walter C Willett; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2014-04-11       Impact factor: 2.506

8.  Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada).

Authors:  H A Risch; M Jain; L D Marrett; G R Howe
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

9.  Kefir induces apoptosis and inhibits cell proliferation in human acute erythroleukemia.

Authors:  Fatemeh Jalali; Mohammadreza Sharifi; Rasoul Salehi
Journal:  Med Oncol       Date:  2015-12-26       Impact factor: 3.064

10.  Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States).

Authors:  B L Harlow; D W Cramer
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.